When ID3 is increased, it inhibits PPARγ protein, and when PPARγ is inhibited by ID3, it further promotes ID3 expression, to gradually enhance the malignancy of colorectal cancer cells and radiotherapy resistance. The gene discussed is ID3; the disease is colorectal cancer.